What are the minimal clinically important differences in the Diabetes Distress Scale–17 and its four subscales?

Adistribution-based minimal clinically important difference (MCID) for the Diabetes Distress Scale–17 (DDS-17) and its four subscales.

Neurofilament light chain identified as early marker for Parkinson’s and dementia with Lewy Bodies

Early detection of Alzheimer’s disease-related changes in Parkinson’s disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated

July 31, 2024

Researchers find differences in how people with impulse control disorder process consequences

Parkinson’s disease is a neurological disorder that affects movement and muscle control. One characteristic of the disease is the deficiency of dopamine, a neurotransmitter or

March 4, 2024

European drug regulator rejects Alzheimer’s drug Leqembi, citing safety concerns

The European Medicines Agency on Friday held its ground against anti-amyloid treatments, saying it will not recommend Eisai and Biogen’s Alzheimer’s drug Leqembi for approval

July 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.